Immunotherapy Research Center (면역치료제연구센터)
Results 21-40 of 112 (Search time: 0.004 seconds).
No. | Year | Title | Type |
---|---|---|---|
92 | 2019 | 2019Patent 미토푸신 억제제를 포함하는, 세포 리프로그래밍 촉진용 조성물 및 이의 용도US14/442,883 (2015.05.14) / 10,494,611 (2019.12.03)조이숙; 권유정; 손명진 |
Patent |
91 | 2019 | 2019Patent 직접 리프로그래밍을 통한 유도 도파민성 전구세포 제조방법US14/908,817 (2016.01.29) / 10,226,486 (2019.03.12)조이숙; 김한섭; 김장환 |
Patent |
90 | 2019 | Report | |
89 | 2019 | 2019Article TSPYL5-mediated inhibition of p53 promotes human endothelial cell functionAngiogenesis, vol. 22, no. 2, pp. 281-293Hee Jun Na; Chung Eun Yeum; Han-Seop Kim; Jungwoon Lee; Jae Yun Kim; Yee Sook Cho |
Article |
88 | 2019 | 2019Article The role of selenium-mediated redox signaling by selenophosphate synthetase 1 (SEPHS1) in hESCsBiochemical and Biophysical Research Communications, vol. 520, no. 2, pp. 406-412Mi Ok Lee; Yee Sook Cho |
Article |
87 | 2019 | 2019Research Project 전분화능 타겟 세포운명전환-특이 RNA 프로세싱 조절 연구 = Studies of RNA processing regulation, which is involved in cell fate conversion into pluripotency연구책임자 : 조이숙 / 사업기간 : 2019.03.01 ~ 2020.02.29 |
Research Project |
86 | 2019 | 2019Research Project 미래형 유전자편집 항암면역세포치료제 개발연구책임자 : 김태돈 / 사업기간 : 2019.09.17 ~ 2020.09.16 |
Research Project |
85 | 2019 | 2019Research Project 유도만능 줄기세포 유래 중간엽기질세포 평가모델 연구연구책임자 : 조이숙 / 사업기간 : 2019.01.01 ~ 2019.12.31 |
Research Project |
84 | 2019 | 2019Research Project 항암 면역세포 치료기술 개발 = Developemnt of anti-cancer immunotherapy연구책임자 : 윤석란 / 사업기간 : 2019.01.01 ~ 2019.12.31 |
Research Project |
83 | 2019 | 2019Research Project 차세대 NK 항암세포치료제 개발을 위한 세포전환-유전자가위 융합기술 개발연구책임자 : 조이숙 / 사업기간 : 2019.10.01 ~ 2020.03.31 |
Research Project |
82 | 2018 | 2018Patent 슈반 세포 전구체 (Schwann cell precursor) 및 이로부터 분화된 슈반 세포 (Schwann cell)의 제조 방법KR10-2017-0009637 (2017.01.20) / 10-1903458 (2018.09.21)김한섭; 조이숙 |
Patent |
81 | 2018 | 2018Patent 미토푸신 억제제를 포함하는, 세포 리프로그래밍 촉진용 조성물 및 이의 용도JP2016-560330 (2015.06.30) / 6386080 (2018.08.17)조이숙; 권유정; 손명진 |
Patent |
80 | 2018 | 2018Patent 섬유증 질환 모델의 제조방법 및 섬유증 질환 모델의 용도KR10-2016-0100282 (2016.08.05) / 10-1844519 (2018.03.27)이미옥; 조이숙 |
Patent |
79 | 2018 | 2018Article DSG2 is a functional cell surface marker for identification and isolation of human pluripotent stem cellsStem Cell Reports, vol. 11, pp. 115-127Jongjin Park; Y Son; Na Geum Lee; Kungmin Lee; Dong Gwang Lee; Jinhoi Song; Jaemin Lee; Seokho Kim; Min Ji Jo; Ju Hong Jang, et al. |
Article |
78 | 2018 | 2018Article Pharmacological regulation of oxidative stress in stem cellsOxidative Medicine and Cellular Longevity, vol. 2018, pp. 4081890-4081890Jung Woon Lee; Yee Sook Cho; Haiyoung Jung; In Pyo Choi |
Article |
77 | 2018 | 2018Article Effects of the extracts from fruit and stem of Camellia japonica on induced pluripotency and wound healing = 전분화능 및 운드힐링에서의 식물추출물 효과Journal of Clinical Medicine, vol. 7, no. 11, pp. 449-449Hyejin Jeon; Jae Yun Kim; Jung Kyun Choi; Enna Han; Cho Lok Song; Jungwoon Lee; Yee Sook Cho |
Article |
76 | 2018 | 2018Article ESRP1-induced CD44 v3 is important for controlling pluripotency in human pluripotent stem cells = 유도만능 줄기세포의 전분화능 조절 ESRP1-CD44 v3Stem Cells, vol. 36, no. 10, pp. 1525-1534Young-Dae Kim; Han-Seop Kim; Jungwoon Lee; Jung Kyun Choi; Enna Han; Ji Eun Jeong; Yee Sook Cho |
Article |
75 | 2018 | 2018Article Generation and fusion of human cortical and medial ganglionic eminence brain organoids = 인간 피질 및 MGE (medial ganglionic eminence) 뇌 organoid의 생산과 융합Current Protocols in Stem Cell Biology, vol. 47, no. 1, pp. e61-e61Y Xiang; T Yoshiaki; B Patterson; B Cakir; K Y Kim; Yee Sook Cho; I H Park |
Article |
74 | 2018 | 2018Article Peroxisome proliferator-activated receptor α agonist and its target Nanog cooperate to induce pluripotency = 전분화능 획득 조절 PPAR 알파 길항제Journal of Clinical Medicine, vol. 7, no. 12, pp. 488-488Jungwoon Lee; Jinhyuk Lee; Yee Sook Cho |
Article |
73 | 2018 | 2018Research Project 전분화능 타겟 세포운명전환-특이 RNA 프로세싱 조절 연구 = Studies of RNA processing regulation, which is involved in cell fate conversion into pluripotency연구책임자 : 조이숙 / 사업기간 : 2018.03.01 ~ 2019.02.28 |
Research Project |